These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1384428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
    Schols D, Wutzler P, Klöcking R, Helbig B, De Clercq E.
    J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N, Schols D, De Clercq E, Debyser Z, Pauwels R, Balzarini J, Nakashima H, Baba M, Hosoya M, Snoeck R.
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The sulfonic acid polymers PAMPS [poly(2-acrylamido-2-methyl-1-propanesulfonic acid)] and related analogues are highly potent inhibitors of angiogenesis.
    Liekens S, Neyts J, Degrève B, De Clercq E.
    Oncol Res; 1997 Dec; 9(4):173-81. PubMed ID: 9268988
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight.
    Cushman M, Wang PL, Chang SH, Wild C, De Clercq E, Schols D, Goldman ME, Bowen JA.
    J Med Chem; 1991 Jan; 34(1):329-37. PubMed ID: 1704065
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action.
    Witvrouw M, Weigold H, Pannecouque C, Schols D, De Clercq E, Holan G.
    J Med Chem; 2000 Mar 09; 43(5):778-83. PubMed ID: 10715146
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes.
    Ding L, Balzarini J, Schols D, Meunier B, de Clercq E.
    Biochem Pharmacol; 1992 Oct 20; 44(8):1675-9. PubMed ID: 1384504
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion.
    Ikeda S, Neyts J, Verma S, Wickramasinghe A, Mohan P, De Clercq E.
    Antimicrob Agents Chemother; 1994 Feb 20; 38(2):256-9. PubMed ID: 8192454
    [Abstract] [Full Text] [Related]

  • 16. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro.
    Balzarini J, Neyts J, Schols D, Hosoya M, Van Damme E, Peumans W, De Clercq E.
    Antiviral Res; 1992 Jun 20; 18(2):191-207. PubMed ID: 1329650
    [Abstract] [Full Text] [Related]

  • 17. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
    Schols D, Pauwels R, Desmyter J, De Clercq E.
    Virology; 1990 Apr 20; 175(2):556-61. PubMed ID: 1691563
    [Abstract] [Full Text] [Related]

  • 18. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
    Jansen RW, Molema G, Pauwels R, Schols D, De Clercq E, Meijer DK.
    Mol Pharmacol; 1991 Jun 20; 39(6):818-23. PubMed ID: 2051994
    [Abstract] [Full Text] [Related]

  • 19. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
    Pal R, Mumbauer S, Hoke G, Larocca R, Myers C, Sarngadharan MG, Stein CA.
    AIDS Res Hum Retroviruses; 1991 Jun 20; 7(6):537-43. PubMed ID: 1718343
    [Abstract] [Full Text] [Related]

  • 20. Significant anti-HIV activity of new modified polyanionic polymers in vitro.
    Buckheit RW, White EL, Shannon WM, Guerrero A, Pivel JP, Carrasco L, Leal JA, Chirigos MA.
    Immunopharmacol Immunotoxicol; 1992 Jun 20; 14(4):707-21. PubMed ID: 1294618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.